Turkish Abstract Abstract Free Full Text English Similar Articles Mail to Author

¹MD, Ankara Etlik City Hospital, Opthalmology Department, Ankara, Türkiye
²MD, Assoc. Prof., Ankara Etlik City Hospital, Opthalmology Department, Ankara, Türkiye
³MD, Prof., Ankara Etlik City Hospital, Opthalmology Department, Ankara, Türkiye DOI : 10.37845/ret.vit.2025.34.35 Summary: Tamoxifen is an anti-estrogenic agent commonly used as adjuvant therapy in hormone receptor-positive breast cancer cases. Among its reported ocular toxicities, retinopathy is the most frequently observed manifestation. Macular telangiectasia type 2, on the other hand, is an idiopathic, bilateral, and asymmetrically progressive retinal vasculopathy that closely resembles Tamoxifen retinopathy in terms of clinical findings. The aim of this article is to provide a comparative evaluation of these two clinically similar pathologies. Keywords : Mac-Tel type 2, macular telangiectasia type 2, Tamoxifen maculopathy, tamoxifen retinopathy